skip to main content
Idioma:
Refinado por: Nome da Publicação: Annals Of Oncology remover assunto: Gynecology. Andrology. Obstetrics remover Biological And Medical Sciences remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now?

Colozza, M. ; Azambuja, E. ; Cardoso, F. ; Sotiriou, C. ; Larsimont, D. ; Piccart, M. J.

Annals of oncology, 2005-11, Vol.16 (11), p.1723-1739 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
2
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites
Material Type:
Artigo 		Adicionar ao Meu Espaço

Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites

Gancberg, D. ; Di Leo, A. ; Cardoso, F. ; Rouas, G. ; Pedrocchi, M. ; Paesmans, M. ; Verhest, A. ; Bernard-Marty, C. ; Piccart, M. J. ; Larsimont, D.

Annals of oncology, 2002-07, Vol.13 (7), p.1036-1043 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
3
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I trial combining temozolomide plus lapatinib for the treatment of brain metastases in patients with HER2-positive metastatic breast cancer: the LAPTEM trial

de Azambuja, E. ; Zardavas, D. ; Lemort, M. ; Rossari, J. ; Moulin, C. ; Buttice, A. ; D'Hondt, V. ; Lebrun, F. ; Lalami, Y. ; Cardoso, F. ; Sotiriou, C. ; Gil, T. ; Devriendt, D. ; Paesmans, M. ; Piccart-Gebhart, M. ; Awada, A.

Annals of oncology, 2013-12, Vol.24 (12), p.2985-2989 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)
Material Type:
Artigo 		Adicionar ao Meu Espaço

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)

Cardoso, F. ; Costa, A. ; Norton, L. ; Senkus, E. ; Aapro, M. ; André, F. ; Barrios, C.H. ; Bergh, J. ; Biganzoli, L. ; Blackwell, K.L. ; Cardoso, M.J. ; Cufer, T. ; El Saghir, N. ; Fallowfield, L. ; Fenech, D. ; Francis, P. ; Gelmon, K. ; Giordano, S.H. ; Gligorov, J. ; Goldhirsch, A. ; Harbeck, N. ; Houssami, N. ; Hudis, C. ; Kaufman, B. ; Krop, I. ; Kyriakides, S. ; Lin, U.N. ; Mayer, M. ; Merjaver, S.D. ; Nordström, E.B. ; Pagani, O. ; Partridge, A. ; Penault-Llorca, F. ; Piccart, M.J. ; Rugo, H. ; Sledge, G. ; Thomssen, C. ; van't Veer, L. ; Vorobiof, D. ; Vrieling, C. ; West, N. ; Xu, B. ; Winer, E.

Annals of oncology, 2014-10, Vol.25 (10), p.1871-1888 [Periódico revisado por pares]

Oxford: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer
HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

HER-2 overexpression/amplification and its interaction with taxane-based therapy in breast cancer

Azambuja, E. ; Durbecq, V. ; Rosa, D. D. ; Colozza, M. ; Larsimont, D. ; Piccart-Gebhart, M. ; Cardoso, F.

Annals of oncology, 2008-02, Vol.19 (2), p.223-232 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
6
Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer
Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancer

Atalay, G. ; Cardoso, F. ; Awada, A. ; Piccart, M. J.

Annals of oncology, 2003-09, Vol.14 (9), p.1346-1363 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
7
Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?
Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Second and subsequent lines of chemotherapy for metastatic breast cancer: what did we learn in the last two decades?

CARDOSO, F ; DI LEO, A ; LOHRISCH, C ; BERNARD, C ; FERREIRA, F ; PICCART, M. J

Annals of oncology, 2002-02, Vol.13 (2), p.197-207 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
8
p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trial
p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

p-53 gene mutations as a predictive marker in a population of advanced breast cancer patients randomly treated with doxorubicin or docetaxel in the context of a phase III clinical trial

Di Leo, A ; Tanner, M ; Desmedt, C ; Paesmans, M ; Cardoso, F ; Durbecq, V ; Chan, S ; Perren, T ; Aapro, M ; Sotiriou, C ; Piccart, MJ ; Larsimont, D ; Isola, J

Annals of oncology, 2007-06, Vol.18 (6), p.997-1003 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
9
Recent advances in adjuvant systemic therapy for early-stage breast cancer
Recent advances in adjuvant systemic therapy for early-stage breast cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Recent advances in adjuvant systemic therapy for early-stage breast cancer

Bedard, P. L. ; Cardoso, F.

Annals of oncology, 2008-07, Vol.19 (suppl-5), p.v122-v127 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por
10
Evaluation of HER2, p53, bcl-2, topoisomerase II-α, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes
Evaluation of HER2, p53, bcl-2, topoisomerase II-α, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Evaluation of HER2, p53, bcl-2, topoisomerase II-α, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodes

Cardoso, F. ; Leo, A. Di ; Larsimont, D. ; Gancberg, D. ; Rouas, G. ; Dolci, S. ; Ferreira, F. ; Paesmans, M. ; Piccart, M.

Annals of oncology, 2001-05, Vol.12 (5), p.615-620 [Periódico revisado por pares]

Oxford: Oxford University Press

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.